北陆药业
(300016)
| 流通市值：45.44亿 | | | 总市值：45.49亿 |
| 流通股本：5.81亿 | | | 总股本：5.82亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,058,562,008.63 | 673,330,527.05 | 320,369,738.33 | 1,205,275,821.64 |
| 营业总成本 | 932,911,671.51 | 588,966,363.56 | 279,988,815.02 | 1,155,065,353.55 |
| 其他经营收益 | | | | |
| 营业利润 | 140,643,435.59 | 101,778,360.58 | 54,903,247.04 | 110,277,745.08 |
| 利润总额 | 139,302,015.5 | 101,035,238.88 | 54,698,115.39 | 108,513,594.24 |
| 净利润 | 121,371,912.74 | 85,171,658.82 | 46,154,383.74 | 88,648,072.01 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 121,371,912.74 | 85,171,658.82 | 46,154,383.74 | 88,648,072.01 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,530,392,168.96 | 1,595,574,266.79 | 1,447,001,060.03 | 1,376,813,154 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,011,095,147.47 | 2,008,186,947.48 | 1,992,257,604.24 | 1,970,715,489.85 |
| 资产总计 | 3,541,487,316.43 | 3,603,761,214.27 | 3,439,258,664.27 | 3,347,528,643.85 |
| 流动负债: | | | | |
| 流动负债合计 | 534,397,389.95 | 605,289,664.4 | 604,902,157.92 | 574,388,433.79 |
| 非流动负债: | | | | |
| 非流动负债合计 | 345,897,046.47 | 339,461,351.56 | 370,068,779.62 | 355,973,906.59 |
| 负债合计 | 880,294,436.42 | 944,751,015.96 | 974,970,937.54 | 930,362,340.38 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,494,652,163.71 | 2,494,732,767.52 | 2,304,355,675.56 | 2,258,719,672.08 |
| 股东权益合计 | 2,661,192,880.01 | 2,659,010,198.31 | 2,464,287,726.73 | 2,417,166,303.47 |
| 负债和股东权益合计 | 3,541,487,316.43 | 3,603,761,214.27 | 3,439,258,664.27 | 3,347,528,643.85 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,169,152,814.23 | 759,328,677.75 | 373,013,408.59 | 1,231,802,634.25 |
| 经营活动现金流出小计 | 968,226,452.72 | 625,542,918.1 | 252,345,482.93 | 1,075,234,604.5 |
| 经营活动产生的现金流量净额 | 200,926,361.51 | 133,785,759.65 | 120,667,925.66 | 156,568,029.75 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,239,327,801.61 | 843,666,144.41 | 413,281,857.74 | 1,293,545,384.92 |
| 投资活动现金流出小计 | 1,293,742,600.49 | 955,721,425.55 | 497,697,154.37 | 1,540,928,938.99 |
| 投资活动产生的现金流量净额 | -54,414,798.88 | -112,055,281.14 | -84,415,296.63 | -247,383,554.07 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 346,758,851.6 | 306,758,851.6 | 111,571,816 | 518,678,138 |
| 筹资活动现金流出小计 | 341,718,374.12 | 159,632,126.9 | 61,943,340.06 | 411,342,874.36 |
| 筹资活动产生的现金流量净额 | 5,040,477.48 | 147,126,724.7 | 49,628,475.94 | 107,335,263.64 |
| 汇率变动对现金及现金等价物的影响 | -4,091,263.48 | -2,845,111.38 | -1,731,670.8 | -1,819,544.12 |
| 现金及现金等价物净增加额 | 147,460,776.63 | 166,012,091.83 | 84,149,434.17 | 14,700,195.2 |
| 期末现金及现金等价物余额 | 379,228,674.43 | 397,779,989.63 | 315,917,331.97 | 231,767,897.8 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 166,012,091.83 | - | 14,700,195.2 |